Biology of the papillomavirus E5 oncoprotein family
乳头瘤病毒 E5 癌蛋白家族的生物学
基本信息
- 批准号:7578852
- 负责人:
- 金额:$ 39.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1991
- 资助国家:美国
- 起止时间:1991-01-01 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:AlkalinizationAnchorage-Independent GrowthAneuploidyBindingBiologicalBiological AssayBiologyC-terminalCancer EtiologyCaveolinsCell Differentiation processCellsCervicalCessation of lifeCharacteristicsCollaborationsCommunicationComplexConnexinsContact InhibitionDetergentsDifferentiation and GrowthEndosomesEpidermal Growth Factor ReceptorEpidermisEvolutionFamilyFibroblastsGap JunctionsGenesGoalsGrantGrowthGrowth Factor ReceptorsHumanHuman papillomavirus 16In VitroInfectionIntercellular JunctionsIntracellular MembranesKnockout MiceKnowledgeLaboratoriesLinkMaintenanceMalignant NeoplasmsMalignant neoplasm of cervix uteriMeasuresMediatingMembraneMembrane LipidsMembrane MicrodomainsModelingMolecular TargetMonitorMusNeoplasmsOncogene ProteinsOncogenesOncogenic VirusesPapillomavirusPhenotypePropertyProtein BindingProteinsResearch PersonnelRiskRoleSignal PathwaySignal TransductionSolubilitySystemTERT geneTP53 geneTransgenic MiceTransplantationTumor Suppressor ProteinsTumorigenicityVesicleVirusWomananticancer researchbasecostdesignhigh riskin vitro activityin vivoinsightkeratinocytemouse modelmutantprogramsprotein functionresearch studytraffickingtumorvacuolar H+-ATPase
项目摘要
The high-risk papillomaviruses are critical etiologic agents in human malignancy, most importantly in cervical
cancer. These oncogenic viruses encode the E6 and E7 proteins that have been shown to modulate cell
growth.and differentiation, target the p53 and Rb tumor suppressor proteins, and induce the hTERT gene
and cellular immortalization. In addition to the E6 and E7 proteins, the high-risk papillomaviruses also
encode the hydrophobic, membrane-associated E5 protein. In recent months, several studies have
established that the evolution of the E5 protein is tightly linked to that of the E6 protein and that the E5 genes
of high-risk papillomaviruses have characteristics that separate them from those of low-risk viruses. The
high-risk HPV-16 E5 protein has a wide spectrum of biological activities, ranging from alterations of growth
factor receptor turnover, MHC transport, endosome acidification, anchorage-independent growth, and
intercellular junction communication. Previously we have shown that the E5 protein binds a component of
the V-ATPase complex and interferes with endosome acidification, thereby giving some insight into how E5
might potentiate the signaling of growth factor receptors. In the current proposal, we have discovered
additional targets for E5, including caveolin and a 116 kDa cellular protein. Based upon our accumulated
knowledge regarding the detergent solubility properties of E5 and the identified E5-associated proteins, we
hypothesize that E5 partitions into membrane lipid rafts and associateswith proteins that are resident in
these signaling platforms. We have constructed a model that conceptually links the identified E5 targets with
the plethora of known E5-induced cellular phenotypes and have designed experiments based upon this
model. The specific delineation of how E5 is targeted to rafts, how it binds to specific raft-resident proteins,
and how is interferes with the functions of these proteins is the focus of this grant. It is anticipated that
insights into E5 functions will illuminate its linkage to HPV-induced malignancy.
高危乳头瘤病毒是人类恶性肿瘤的关键病原体,最重要的是宫颈癌。
癌症。这些致癌病毒编码 E6 和 E7 蛋白,已被证明可以调节细胞
生长和分化,靶向 p53 和 Rb 肿瘤抑制蛋白,并诱导 hTERT 基因
和细胞永生化。除了E6和E7蛋白外,高危乳头瘤病毒还
编码疏水性膜相关 E5 蛋白。近几个月来,多项研究表明
确定 E5 蛋白的进化与 E6 蛋白的进化紧密相关,并且 E5 基因
高风险乳头瘤病毒具有与低风险病毒不同的特征。这
高危 HPV-16 E5 蛋白具有广泛的生物活性,包括改变生长
因子受体周转、MHC 转运、内体酸化、不依赖锚定的生长和
细胞间连接通讯。之前我们已经证明 E5 蛋白结合了
V-ATP酶复合物并干扰内体酸化,从而深入了解E5如何
可能会增强生长因子受体的信号传导。在当前的提案中,我们发现
E5 的其他靶标,包括小窝蛋白和 116 kDa 细胞蛋白。根据我们积累的
关于 E5 的洗涤剂溶解度特性和已鉴定的 E5 相关蛋白的知识,我们
假设 E5 划分成膜脂筏并与驻留在其中的蛋白质结合
这些信号平台。我们构建了一个模型,在概念上将已识别的 E5 目标与
大量已知的 E5 诱导的细胞表型,并基于此设计了实验
模型。 E5如何靶向筏、如何与特定筏驻留蛋白结合的具体描述,
如何干扰这些蛋白质的功能是本次资助的重点。预计
对 E5 功能的深入了解将阐明其与 HPV 诱发的恶性肿瘤的联系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Richard Schlegel其他文献
Richard Schlegel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Richard Schlegel', 18)}}的其他基金
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8899468 - 财政年份:2013
- 资助金额:
$ 39.06万 - 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8727495 - 财政年份:2013
- 资助金额:
$ 39.06万 - 项目类别:
Conditionally reprogrammed cells as a novel tool for biobanking
条件重编程细胞作为生物样本库的新工具
- 批准号:
8547303 - 财政年份:2013
- 资助金额:
$ 39.06万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8516613 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8725249 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8322566 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
Emerging Papillomaviruses in Immunosuppressed Dogs
免疫抑制犬中新出现的乳头瘤病毒
- 批准号:
8137493 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
- 批准号:
7286845 - 财政年份:2006
- 资助金额:
$ 39.06万 - 项目类别:
A topical treatment for genital papillomavirus infections
生殖器乳头瘤病毒感染的局部治疗
- 批准号:
7174571 - 财政年份:2006
- 资助金额:
$ 39.06万 - 项目类别:
HPV E6 protein regulation of the hTERT promoter
HPV E6 蛋白对 hTERT 启动子的调节
- 批准号:
6757107 - 财政年份:2004
- 资助金额:
$ 39.06万 - 项目类别:
相似海外基金
Role of anchorage-independent growth regulation in tumor progression
不依赖锚定的生长调节在肿瘤进展中的作用
- 批准号:
15K06829 - 财政年份:2015
- 资助金额:
$ 39.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Understanding the molecular mechanism required for an anchorage-independent growth of CD133-positive ovarian cancer cells
了解 CD133 阳性卵巢癌细胞非贴壁依赖性生长所需的分子机制
- 批准号:
23800055 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Anchorage-independent growth and EMT relationship in esophageal cancer.
食管癌的锚定非依赖性生长和 EMT 关系。
- 批准号:
23659637 - 财政年份:2011
- 资助金额:
$ 39.06万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Functional analysis of a novel signal molecule CDCP1 which regulates anchorage-independent growth in cancer cells
调节癌细胞贴壁依赖性生长的新型信号分子CDCP1的功能分析
- 批准号:
21590350 - 财政年份:2009
- 资助金额:
$ 39.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathophysiology of lymphatic stomata in the pathogenesis of cancerous pleural effusion and mechanisms of anchorage-independent growth of cancer
癌性胸腔积液发病机制中淋巴气孔的病理生理学和癌症非锚定依赖性生长机制
- 批准号:
20790993 - 财政年份:2008
- 资助金额:
$ 39.06万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
- 批准号:
6513557 - 财政年份:2000
- 资助金额:
$ 39.06万 - 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
- 批准号:
6633392 - 财政年份:2000
- 资助金额:
$ 39.06万 - 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
- 批准号:
6042591 - 财政年份:2000
- 资助金额:
$ 39.06万 - 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
- 批准号:
6377153 - 财政年份:2000
- 资助金额:
$ 39.06万 - 项目类别:
ANCHORAGE INDEPENDENT GROWTH INDUCED BY CDC42
CDC42 带来的安克雷奇独立增长
- 批准号:
6771684 - 财政年份:2000
- 资助金额:
$ 39.06万 - 项目类别: